Randomized phase II trial evaluating the optimal sequencing of sipuleucel-T and androgen-deprivation therapy (ADT) in patients (pts) with biochemically recurrent prostate cancer (BRPC).
Emmanuel S. Antonarakis
Consultant or Advisory Role - Dendreon; Dendreon; Dendreon
Research Funding - Dendreon; Dendreon; Dendreon
Adam Kibel
Consultant or Advisory Role - Dendreon
Robert Claude Tyler
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Candice McCoy
Employment or Leadership Position - Dendreon; Dendreon
Stock Ownership - Dendreon; Dendreon
Yang Wang
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Charles G. Drake
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Dendreon